• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高分辨率正电子发射显微镜对患者来源的肿瘤类器官进行成像。

High-resolution positron emission microscopy of patient-derived tumor organoids.

机构信息

Department of Radiation Oncology, Division of Medical Physics, Stanford University School of Medicine, Stanford, USA.

Department of Otolaryngology, Division of Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

Nat Commun. 2021 Oct 7;12(1):5883. doi: 10.1038/s41467-021-26081-6.

DOI:10.1038/s41467-021-26081-6
PMID:34620852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8497512/
Abstract

Tumor organoids offer new opportunities for translational cancer research, but unlike animal models, their broader use is hindered by the lack of clinically relevant imaging endpoints. Here, we present a positron-emission microscopy method for imaging clinical radiotracers in patient-derived tumor organoids with spatial resolution 100-fold better than clinical positron emission tomography (PET). Using this method, we quantify F-fluorodeoxyglucose influx to show that patient-derived tumor organoids recapitulate the glycolytic activity of the tumor of origin, and thus, could be used to predict therapeutic response in vitro. Similarly, we measure sodium-iodine symporter activity using Tc- pertechnetate and find that the iodine uptake pathway is functionally conserved in organoids derived from thyroid carcinomas. In conclusion, organoids can be imaged using clinical radiotracers, which opens new possibilities for identifying promising drug candidates and radiotracers, personalizing treatment regimens, and incorporating clinical imaging biomarkers in organoid-based co-clinical trials.

摘要

肿瘤类器官为转化癌症研究提供了新的机会,但与动物模型不同的是,由于缺乏临床相关的影像学终点,其更广泛的应用受到了阻碍。在这里,我们提出了一种正电子发射显微镜方法,用于对患者来源的肿瘤类器官中的临床放射性示踪剂进行成像,其空间分辨率比临床正电子发射断层扫描(PET)高出 100 倍。使用这种方法,我们定量测量 F-氟脱氧葡萄糖的流入,以表明患者来源的肿瘤类器官再现了起源肿瘤的糖酵解活性,因此,可用于体外预测治疗反应。同样,我们使用 Tc-高锝酸盐测量钠碘同向转运体的活性,发现碘摄取途径在甲状腺癌衍生的类器官中是功能保守的。总之,临床放射性示踪剂可用于对类器官进行成像,这为鉴定有前途的候选药物和放射性示踪剂、制定个体化治疗方案以及将临床影像学生物标志物纳入基于类器官的临床试验提供了新的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/b6de41d5c0a6/41467_2021_26081_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/770295c1103d/41467_2021_26081_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/9c1f7566f930/41467_2021_26081_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/c91adf020a46/41467_2021_26081_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/83036c3243b1/41467_2021_26081_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/536eacd5e43f/41467_2021_26081_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/b6de41d5c0a6/41467_2021_26081_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/770295c1103d/41467_2021_26081_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/9c1f7566f930/41467_2021_26081_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/c91adf020a46/41467_2021_26081_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/83036c3243b1/41467_2021_26081_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/536eacd5e43f/41467_2021_26081_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/8497512/b6de41d5c0a6/41467_2021_26081_Fig6_HTML.jpg

相似文献

1
High-resolution positron emission microscopy of patient-derived tumor organoids.高分辨率正电子发射显微镜对患者来源的肿瘤类器官进行成像。
Nat Commun. 2021 Oct 7;12(1):5883. doi: 10.1038/s41467-021-26081-6.
2
Mismatch of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and Tc-99m pertechnetate single photon emission computed tomography (SPECT) in a euthyroid multinodular goiter.正常甲状腺功能的多结节性甲状腺肿中F-18氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)与锝-99m高锝酸盐单光子发射计算机断层扫描(SPECT)的不匹配
Clin Nucl Med. 2007 Jan;32(1):6-8. doi: 10.1097/01.rlu.0000249400.15603.f3.
3
Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer.99m锝-高锝酸盐和123碘单光子发射计算机断层扫描(SPECT)与氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在疑似乳腺癌患者中的比较
Cancer Biother Radiopharm. 2007 Dec;22(6):779-89. doi: 10.1089/cbr.2007.358.
4
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.甲状腺球蛋白、放射性碘成像及正电子发射断层扫描在甲状腺癌评估中的各自作用。
Semin Nucl Med. 2006 Jul;36(3):194-205. doi: 10.1053/j.semnuclmed.2006.03.002.
5
Positron Emission Tomography/Computed Tomography in Thyroid Cancer: An Updated Review.正电子发射断层扫描/计算机断层扫描在甲状腺癌中的应用:更新综述。
PET Clin. 2024 Apr;19(2):131-145. doi: 10.1016/j.cpet.2023.12.001. Epub 2024 Jan 10.
6
Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.18F-FDG 全身PET、99mTc-MIBI单光子发射计算机断层显像(SPET)及治疗后131I-Na闪烁扫描术在转移性甲状腺癌检测中的比较
Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):491-8. doi: 10.1007/s00259-003-1403-y. Epub 2003 Dec 10.
7
Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.杂项癌症(肺癌、甲状腺癌、肾癌、骨髓瘤和神经内分泌肿瘤):SPECT 和 PET 在骨转移成像中的作用。
Semin Nucl Med. 2009 Nov;39(6):416-30. doi: 10.1053/j.semnuclmed.2009.07.002.
8
I-124-PET/US Fusion Imaging in Comparison to Conventional Diagnostics and Tc-99m Pertechnetate SPECT/US Fusion Imaging for the Function Assessment of Thyroid Nodules.I-124-PET/US 融合显像与常规诊断及 Tc-99m 高锝酸盐 SPECT/US 融合显像在甲状腺结节功能评估中的比较。
Ultrasound Med Biol. 2019 Sep;45(9):2298-2308. doi: 10.1016/j.ultrasmedbio.2019.05.008. Epub 2019 Jun 10.
9
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.葡萄糖转运蛋白 1 表达、肿瘤增殖以及甲状腺癌中的碘/葡萄糖摄取,重点是低分化甲状腺癌。
Clin Nucl Med. 2012 Feb;37(2):121-7. doi: 10.1097/RLU.0b013e3182393599.
10
Feasibility and utility of MRI and dynamic F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer.基于器官型子宫内膜癌患者来源的小鼠模型的 MRI 和动态 F-FDG-PET 的可行性和实用性。
J Transl Med. 2021 Sep 26;19(1):406. doi: 10.1186/s12967-021-03086-9.

引用本文的文献

1
Organ-on-a-chip systems for modeling tumor and normal tissue microenvironments in radiotherapy research.用于放射治疗研究中肿瘤和正常组织微环境建模的芯片器官系统。
Trends Biotechnol. 2025 Jul 24. doi: 10.1016/j.tibtech.2025.07.002.
2
Strategies to overcome the limitations of current organoid technology - engineered organoids.克服当前类器官技术局限性的策略——工程化类器官。
J Tissue Eng. 2025 Apr 15;16:20417314251319475. doi: 10.1177/20417314251319475. eCollection 2025 Jan-Dec.
3
Bioprinting of Cells, Organoids and Organs-on-a-Chip Together with Hydrogels Improves Structural and Mechanical Cues.

本文引用的文献

1
High-resolution radioluminescence microscopy of FDG uptake in an engineered 3D tumor-stoma model.高分辨率辐射发光显微镜在三维工程肿瘤-窦道模型中观察 FDG 摄取。
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3400-3407. doi: 10.1007/s00259-021-05364-6. Epub 2021 Apr 21.
2
Cell-programmed nutrient partitioning in the tumour microenvironment.肿瘤微环境中的细胞程序性营养分配。
Nature. 2021 May;593(7858):282-288. doi: 10.1038/s41586-021-03442-1. Epub 2021 Apr 7.
3
Single Cell Glucose Uptake Assays: A Cautionary Tale.单细胞葡萄糖摄取测定:一个警示故事。
细胞、类器官和芯片上器官与水凝胶的生物打印提高了结构和机械线索。
Cells. 2024 Oct 1;13(19):1638. doi: 10.3390/cells13191638.
4
An in vivo tumour organoid model based on the chick embryonic chorioallantoic membrane mimics key characteristics of the patient tissue: a proof-of-concept study.基于鸡胚绒毛尿囊膜的体内肿瘤类器官模型模拟患者组织的关键特征:一项概念验证研究。
EJNMMI Res. 2024 Sep 27;14(1):86. doi: 10.1186/s13550-024-01151-0.
5
Engineered organoids for biomedical applications.用于生物医学应用的工程类器官
Adv Drug Deliv Rev. 2023 Dec;203:115142. doi: 10.1016/j.addr.2023.115142. Epub 2023 Nov 13.
6
Brain organoids: Establishment and application.脑类器官:建立与应用。
Front Cell Dev Biol. 2022 Nov 23;10:1029873. doi: 10.3389/fcell.2022.1029873. eCollection 2022.
7
Development of a Lensless Radiomicroscope for Cellular-Resolution Radionuclide Imaging.无镜头无线电显微镜的开发用于细胞分辨率放射性核素成像。
J Nucl Med. 2023 Mar;64(3):479-484. doi: 10.2967/jnumed.122.264021. Epub 2022 Sep 15.
8
Patient-derived cancer models: Valuable platforms for anticancer drug testing.患者来源的癌症模型:抗癌药物测试的宝贵平台。
Front Oncol. 2022 Aug 12;12:976065. doi: 10.3389/fonc.2022.976065. eCollection 2022.
Immunometabolism. 2020 Aug 17;2(4):e200029. doi: 10.20900/immunometab20200029. eCollection 2020.
4
Organoid Models of Tumor Immunology.肿瘤免疫学的类器官模型。
Trends Immunol. 2020 Aug;41(8):652-664. doi: 10.1016/j.it.2020.06.010. Epub 2020 Jul 9.
5
Label-free redox imaging of patient-derived organoids using selective plane illumination microscopy.使用选择性平面照明显微镜对患者来源的类器官进行无标记氧化还原成像。
Biomed Opt Express. 2020 Apr 16;11(5):2591-2606. doi: 10.1364/BOE.389164. eCollection 2020 May 1.
6
Recent advances of PET imaging in clinical radiation oncology.正电子发射断层扫描成像在临床放射肿瘤学中的新进展。
Radiat Oncol. 2020 Apr 21;15(1):88. doi: 10.1186/s13014-020-01519-1.
7
Zebrafish patient avatars in cancer biology and precision cancer therapy.斑马鱼患者生物信息学模型在癌症生物学和精准肿瘤治疗中的应用
Nat Rev Cancer. 2020 May;20(5):263-273. doi: 10.1038/s41568-020-0252-3. Epub 2020 Apr 6.
8
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.利用源于基因工程多能干细胞的癌症化身进行肿瘤发展的纵向评估。
Nat Commun. 2020 Jan 28;11(1):550. doi: 10.1038/s41467-020-14312-1.
9
Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer.患者来源类器官预测局部晚期直肠癌的放化疗反应。
Cell Stem Cell. 2020 Jan 2;26(1):17-26.e6. doi: 10.1016/j.stem.2019.10.010. Epub 2019 Nov 21.
10
Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors.患者来源的类器官作为预测 PD-1/PD-L1 检查点抑制剂反应的潜在模型。
Br J Cancer. 2019 Nov;121(11):979-982. doi: 10.1038/s41416-019-0616-1. Epub 2019 Oct 31.